Abingdon Health (LON:ABDX) Trading Up 35.8% – Still a Buy?

Abingdon Health Plc (LON:ABDX) shares traded up 35.8% during mid-day trading on Tuesday . The stock traded as high as GBX 11.29 and last traded at GBX 11.17. 1,147,897 shares were traded during trading, an increase of 405% from the average session volume of 227,213 shares. The stock had previously closed at GBX 8.23.

Abingdon Health Stock Up 31.1%

The firm’s 50-day moving average price is GBX 8.06 and its 200-day moving average price is GBX 7.07. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The company has a market cap of £27.08 million, a price-to-earnings ratio of -13.32 and a beta of 0.25.

Abingdon Health (LON:ABDX) last posted its earnings results on Tuesday, March 17th. The company reported GBX (0.43) earnings per share for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.